key: cord-0845636-9n9vn58e authors: Hu, Bintao; Ruan, Yajun; Liu, Kang; Wei, Xian; Wu, Yue; Feng, Huan; Deng, Zhiyao; Liu, Jihong; Wang, Tao title: A Mid-to-Long Term Comprehensive Evaluation of Psychological Distress and Erectile Function in COVID-19 Recovered Patients date: 2021-08-26 journal: J Sex Med DOI: 10.1016/j.jsxm.2021.08.010 sha: c348800cec8b4b0238d951f466cf77fb8cede526 doc_id: 845636 cord_uid: 9n9vn58e BACKGROUND: The psychological and sexual health of different populations are negatively affected during the COVID-19 pandemic. However, little is known about psychological distress and erectile function of male recovered patients with COVID-19 in the long term. AIM: we aimed to evaluate psychological distress and erectile function of male recovered patients with COVID-19 in the mid-to-long terms. METHODS: We recruited 67 eligible male recovered patients with COVID-19 and followed them up twice within approximately 6 months of recovery time. The psychological distress and erectile function were assessed by validated Chinese version of paper questionnaires. OUTCOMES: The primary outcomes were Symptom Checklist 90 (SCL-90) questionnaire for psychological distress and International Index of Erectile Function-5 (IIEF-5) for erectile function. RESULTS: In the first visit, COVID-19 patients with a median recovery time of 80 days mainly presented the following positive symptoms: OC, ADD, HOS, IS, DEP, and SOM; while the dimension scores in SOM, ANX, ADD, and PHOB were higher than Chinese male norms. Besides, the prevalence of ED in the first-visit patients was significantly higher than Chinese controls. In the second visit, the primary psychological symptoms of COVID-19 patients with a median recovery time of 174 days were OC, ADD, IS, and HOS, while all dimensions scores of SCL-90 were lower than Chinese male norms. Moreover, second-visit patients had no significant difference with Chinese controls in ED prevalence. In addition, it suggested that GSI was the independent risk factor for ED in the regression analysis for the first-visit patients. CLINICAL IMPLICATIONS: The study showed the changes of psychological symptoms and erectile function in COVID-19 recovered patients, and provided reference on whether psychological and sexual supports are needed after a period of recovery. STRENGTHS AND LIMITATIONS: To our knowledge, it is the first study to comprehensively evaluate the psychological distress and erectile function of COVID-19 recovered patients in the mid-to-long terms. The main limitations were the low number of analyzed participants, and the psychological distress and erectile function of healthy Chinese men over the same period were not evaluated, and the psychological and sexual related data of participants prior to COVID-19 were not available. Additionally, there was a selection bias in comparing COVID-19 patients with healthy controls. CONCLUSION: With less impact of COVID-19 event, the impaired erectile function and psychological distress improved in COVID-19 recovered patients with a recovery time of nearly half a year. B Hu, Y Ruan, K Liu, et al. A Mid-to-Long Term Comprehensive Evaluation of Psychological Distress and Erectile Function in COVID-19 Recovered Patients. J Sex Med 2021;XX:XXX–XXX. Generally speaking, the outbreak of a pandemic will cause a crisis of psychological health 4, 5 . During the pandemic, people's daily lives were significantly changed owing to the various disease-prevention measures 6, 7. General population experienced the loss of freedom, separation from families and friends, difficulties in securing medications, as well as the obvious economic consequences of lockdown. Health workers had an additional experience of health-threatening workload and high risk of being infected 8 . While the COVID-19 patients additionally faced the fear of dying from the disease, facing discrimination and getting stigmatized by the society 9, 10 . Therefore, it was not surprising that the public was stressed and had various degrees of psychological distress, and the burden of these psychological morbidities was highest among the COVID-19 patients, followed by healthcare workers and general population amidst the COVID-19 pandemic 10 . Unfortunately, as previous studies on Severe acute respiratory syndrome (SARS) and Middle East Respiratory Syndrome (MERS) survivors indicated persistent mental disorder even after 1 year 11, 12 , it's likely that COVID-19-related psychological distress will persist long after recovery. However, few studies reported the long-term psychological impact of COVID-19 on recovered patients. Additionally, as both psychological and physiological components can potentially be involved in the relationship between stress and sexual function 13 27 , it is significant to evaluate their erectile function in the mid-to-long terms. In this study, we followed up male recovered patients with COVID-19 for approximately half a year and comprehensively evaluated their psychological distress and erectile function through the paper questionnaires completed. It can provide insights into the changes of psychological symptoms and erectile function in COVID-19 recovered patients and whether they need psychological and sexual support after a period of recovery. In order to evaluate the psychological distress and erectile function of male recovered patients with COVID-19 in the mid-to-long term, we designed a prospective observational study for approximately six months. The study was registered with ClinicalTrials.gov, number XXX, and was approved by the Ethics Committee of XXX College (XXX). All participants gave written informed consent before starting the survey. All the information for patients, including demographic data, clinical characteristics, as well as psychometric and sexological measures, were collected in the case report form. To ensure that there were no errors and duplicated information, two researchers independently converted the information of case report form into electronic records. Data were analyzed and interpreted by the authors. The objects of this study were male COVID-19 recovered patients with denying The controls for comparison with COVID-19 recovered patients were obtained from two pieces of literature investigating the psychological distress and ED prevalence of large-scale Chinese men population respectively 28, 29. One of the controls ageing from 18 to 60 years (regarded as Chinese male norms) was obtained by cluster sampling in 12 Chinese provinces, and they had no history of mental disorders. The other controls between 22 and 60 years old were selected by a cross-sectional survey in different parts of China, and all of them were married and have had past intercourse experience. In May 2020, we contacted the male COVID-19 patients discharged from Wuhan Tongji hospital and prescreened the patients according to the inclusion and exclusion criteria. 67 patients were enrolled in this study. After signing the informed consent form, they were asked to attend the andrological laboratory and complete related examinations. The International Index of Erectile Function-5 (IIEF-5) and Symptom Checklist 90 (SCL-90) questionnaire were instructed to complete for evaluating erectile function and psychological distress, respectively. Three months later (in August 2020), we tried to get in touch with the last eligible participants. However, only 30 eligible questionnaires of IIEF-5 and SCL-90 were completed. Chinese version, a 5-item scale scored from 1 to 5 assessing maintenance ability, erection confidence, maintenance frequency, erection firmness, and intercourse satisfaction. Total scores of 22-25, 12-21, 8-11, and 5-7 were considered to represent normal, mild, moderate, and severe ED, respectively. The cut-off value for ED was specified as 21 30 . All the questionnaire data were electronically stored with the SPSS statistical software version 25 (IBM) for statistical analysis. The Mann-Whitney U test or independent t test was used to assess the statistical significance of continuous variables. For the categorical variables, the statistical difference among groups was determined by using Pearson's chi-square or Fisher's exact test. Univariate and multivariate logistic regression analyses were performed to explore the risk factors of ED. Statistical significance was accepted as P < 0.05. In this study, we followed the enrolled subjects up in May and August 2020 respectively. After strictly prescreening according to inclusion and exclusion days. There was no statistically significant difference between first-visit and second-visit patients in demographic and clinical characteristics, including age, BMI, the rate of smoking and drinking, marriage status, and classification of illness. The prevalence of ED and GSI in second-visit patients were both lower than in first-visit patients, although not statistically significant. Table 2 and Table 3 HOS symptoms (13.33%) occurred in more than 10% of recovered patients in August. In addition, we made comparisons of SCL-90 scores between recovered patients of different periods and the Chinese male norms (Table 4 and Table 5 ). It indicated that first-visit patients had higher scores in somatization, anxiety, phobia and additional items, and lower scores in the other symptoms than Chinese male norms, although not significant except for paranoid ideation in Table 4 . Chinese men as a control group in this study. The recovered patients were compared with them (Table 6 ). It exhibited that ED prevalence of first-visit patients was significantly higher than controls, while the second-visit patients showed no significant difference with controls. To explore the risk factors of ED in the first-visit patients, we performed univariate and multivariate logistic regression analysis ( Table 7) . The factors whose p value in univariate analysis was less than 0.3 (namely age, BMI, marital status and GSI) were included in the multivariate model. Multivariate analysis indicated that GSI was an independent risk factor for ED in the first-visit patients (OR: 8.697, P=0.015). COVID-19 is a highly infectious disease and could result in multiorgan dysfunction syndrome and death 38 . COVID-19 recovered patients might experience social isolation, death of family members, and perceived stigma and discrimination by others owing to the history of COVID-19. In addition, critical patients with COVID-19 might have the concern about the sequelae of corticosteroid treatment and ICU-acquired weakness which contribute to adverse long-term psychological sequelae 39 . Certainly, financial stressors due to the lockdown and quarantine are potential contributors to psychological disorders 40 . In this study, we explored whether the history of COVID-19 severity was the risk factor for psychological distress, and it suggested that the history of COVID-19 infection severity was not associated with psychological distress (supplementary table 1). In the published reports, it revealed that the main risk factors for these psychological disorders in recovered patients with COVID-19 were perceived stigma and discrimination, although they had recovered and were not infectious 36, 37 . In addition to the residual psychological disorders, various proportions of recovered COVID-19 patients still experienced fatigue, breath shortness, headache, and chest pain after discharged one or two months later 35 Knowledge about COVID-19 was gradually clearer. Alternatively, it might be attributed to the participants in this study with fewer risk factors for persistent psychological disorders, such as previous psychiatric history, presence of a family member who died from COVID-19, and so on 12 . ED refers to the inability to sustain or achieve an erection sufficient for satisfactory intercourse 44 . During the COVID-19 pandemic period, it was reported that there was a significant increase in the diagnostic rate of ED among male patients presenting to the outpatient urology clinics compared with the pre-COVID-19 pandemic period 23 . An online survey on the sexual health of 217 males through IIEF-5 questionnaire reported 31.8% of ED prevalence 26 . Moreover, ED was seen at higher rates in the healthcare professionals group compared with the control group 24 . However, few studies were specifically conducted on COVID-19 patients for erectile function. Here, we also evaluated the erectile function of COVID-19 recovered patients for about six months. It revealed that recovered patients had impaired erectile function along with psychological distress in the first visit. However, it remained unclear whether the impaired erectile function was psychogenic or combined organic. Hence, we followed them up further. It showed improved erectile function along with an elevated psychological state in the second visit. As organic ED is not completely reversible, we speculated that ED for first-visit patients was mainly psychogenic. The etiology of ED involves multiple factors which often coexist, including psychogenic, organic (neurogenic, hormonal, vasculogenic, or drug-induced) and some other factors 45 which suggested impaired endothelial function in COVID-19 (+) patients 48 . In addition, the common comorbidities of COVID-19 patients were diabetes, hypertension, chronic kidney disease and heart disease 49 , and some complications of COVID-19, such as arrhythmia, acute kidney injury, could occur in the patients 50 . Therefore, it was likely that some pharmacological treatments of COVID-19, such as the use of antihypertensive and antiarrhythmic drugs which were commonly associated with ED 51 , could contribute to the pathogenesis of ED. As a matter of fact, it was reported that the prevalence of ED in COVID-19 patients was significantly higher 52 . At 6 months after acute infection with COVID-19, a certain proportion of recovered patients remained diffusion impairment, and patients who were more severely ill during their hospital stay had more severe impaired pulmonary diffusion capacities and abnormal chest imaging manifestation 43 . Therefore, it was likely that the erectile function in COVID-19 patients with a recovery time of 80 days was impaired. To explore the risk factors of ED in the first-visit patients with COVID-19, we performed univariate and multivariate logistic regression analysis. GSI was the only independent risk factor in the multivariate analysis for ED. It In addition to the impact on erectile function, COVID-19 could also impair sperm quality in terms of male sexual health. Angiotensin-converting enzyme 2 (ACE2), reported as a SARS-CoV-2 receptor, existed in almost all human testis cells, suggesting a potential effect on male fertility 53 . Actually, some of COVID-19 patients experienced scrotal discomfort 54 , and some autopsy reports of COVID-19 patients showed that there was edema, inflammatory infiltrates, and various degrees of spermatogenic cell reduction and injury in the testes 55, 56 , which revealed that COVID-19 damaged the testis. Moreover, some of the reports revealed that COVID-19 recovered patients presented impaired sperm quality [57] [58] [59] . In this study, we analyzed the changes of psychological distress and erectile function for COVID-19 patients within around 6 months of recovery time. To our knowledge, it is the first study to comprehensively evaluate the psychological distress and erectile function of COVID-19 recovered patients for such a long time. Admittedly, there are several limitations in our study. Firstly, it was an observational study, which limited the cause inference. And we did not evaluate the psychological distress and ED prevalence of healthy Chinese men over the same period, which made it hard to confirm whether the ED and psychological disorders were caused by the COVID-19 disease or the pandemic event. Secondly, we did not have any assessment of mental health and erectile function prior to COVID-19; thus we were unable to ascertain if psychological symptoms or ED were preexisting. Additionally, there was a selection bias in comparing COVID-19 patients with healthy controls, as COVID-19 patients are overall more likely sick at baseline with more comorbidities than healthy controls. Finally, the sample size in this study was relatively small for assessing ED prevalence and psychological distress. A larger number of COVID-19 recovered patients and healthy men over the same period are needed to clarify the dynamic changes of psychological and sexual health in the longer term and determine whether the psychological and sexual disorders are affected by the disease or by the pandemic event after recovery. With the pandemic contained and more knowledge about COVID-19, the impaired erectile function and psychological distress improved in patients who were recovered from COVID-19 for nearly half a year while without detailed clinical information on the viral infection. It is of great significance for maintaining physical and psychological health to explore SARS-CoV-2 objectively and face COVID-19 positively. Conflict of interest: The authors report no conflicts of interest. Return of the Coronavirus: 2019-nCoV COVID-19: extending or relaxing distancing control measures The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study Prevalence of psychological symptoms among Ebola survivors and healthcare workers during the 2014-2015 Ebola outbreak in Sierra Leone: a cross-sectional study The immediate psychological and occupational impact of the 2003 SARS outbreak in a teaching hospital Psychological status and behavior changes of the public during the COVID-19 epidemic in China Forecasting the Future of Urology Practice: A Comprehensive Review of the Recommendations by International and European Associations on Priority Procedures During the COVID-19 Pandemic COVID-19: anxiety among hospital staff and associated factors Prevalence of psychological morbidities among general population, healthcare workers and COVID-19 patients amidst the COVID-19 pandemic: A systematic review and meta-analysis Long-term psychiatric morbidities among SARS survivors Posttraumatic stress disorder and depression of survivors 12 months after the outbreak of Middle East respiratory syndrome in South Korea Effects of Aversive Classical Conditioning on Sexual Response in Women With Dyspareunia and Sexually Functional Controls An Online Questionnaire Survey on the Sexual Life and Sexual Function of Chinese Adult Men During the Coronavirus Disease Examination of the effect of COVID-19 on sexual dysfunction in women Love in the Time of COVID-19: Sexual Function and Quality of Life Analysis During the Social Distancing Measures in a Group of Italian Reproductive-Age Women The Impact of the COVID-19 Quarantine on Sexual Life in Italy The Interface of Systems Medicine and Sexual Medicine for Facing Non-Communicable Diseases in a Gender-Dependent Manner Testicular pain as an unusual presentation of COVID-19: a brief review of SARS-CoV-2 and the testis Cardiovascular Manifestations of COVID-19 Pulmonary fibrosis secondary to COVID-19: a call to arms? Addressing male sexual and reproductive health in the wake of COVID-19 outbreak Variations in the Number of Patients Presenting With Andrological Problems During the Coronavirus Disease Pandemic and the Possible Reasons for These Variations: A Multicenter Study The effect of COVID-19 epidemic on the sexual function of healthcare professionals Influence of COVID-19 pandemic on sexuality: a cross-sectional study among couples in Turkey Psychological and Sexual Health During the COVID-19 Pandemic in Egypt: Are Women Suffering More? Clinical Characteristics of Coronavirus Disease 2019 in China A survey of mental symptoms of Chinese population based on SCL-90 The prevalence of erectile dysfunction and its relation to chronic prostatitis in Chinese men Prevalence of sexual dysfunction in Chinese men with chronic prostatitis Psychological symptoms of ordinary Chinese citizens based on SCL-90 during the level I emergency response to COVID-19 Psychological sequelae within different populations during the COVID-19 pandemic: a rapid review of extant evidence The prevalence of depression, anxiety, and sleep disturbances in COVID-19 patients: a meta-analysis Psychological outcomes after hospitalization for COVID-19: data from a multidisciplinary follow-up screening program for recovered patients Chest radiography is a poor predictor of respiratory symptoms and functional impairment in survivors of severe COVID-19 pneumonia Risk factors associated with mental illness in hospital discharged patients infected with COVID-19 in Wuhan, China Psychological Consequences of Survivors of COVID-19 Pneumonia 1 Month after Discharge Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Functional disability 5 years after acute respiratory distress syndrome COVID-19, unemployment, and suicide Persistent Symptoms in Patients After Acute COVID-19 Clinical characteristics and follow-up analysis of 324 discharged COVID-19 patients in Shenzhen during the recovery period 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence Erectile dysfunction SARS-CoV-2: a storm is raging From inflammation to sexual dysfunctions: a journey through diabetes, obesity, and metabolic syndrome COVID-19 Endothelial Dysfunction Can Cause Erectile Dysfunction: Histopathological, Immunohistochemical, and Ultrastructural Study of the Human Penis Clinical characteristic and epidemiological features of SARS CoV -2 disease patients from a COVID 19 designated Hospital in New Delhi Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China Erectile dysfunction Mask up to keep it up": Preliminary evidence of the association between erectile dysfunction and COVID-19 Single-cell transcriptome analysis of the novel coronavirus (SARS-CoV-2) associated gene ACE2 expression in normal and non-obstructive azoospermia (NOA) human male testes No evidence of severe acute respiratory syndrome-coronavirus 2 in semen of males recovering from coronavirus disease Autopsy of COVID-19 patients in China Pathological Findings in the Testes of COVID-19 Patients: Clinical Implications Assessment of SARS-CoV-2 in human semen-a cohort study Evaluation of sex-related hormones and semen characteristics in reproductive-aged male COVID-19 patients No Detection of SARS-CoV-2 from Urine, Expressed Prostatic Secretions and Semen in 74 Recovered COVID-19 Male Patients: A Perspective and Urogenital Evaluation OR = odds ratio